Antibacterial Activity of Leaf Extracts of Anredera cordifolia (Ten.) Steenis and Muntingia calabura L. Against Streptococcus pneumoniae by Nasution, Nuke Annisa et al.
Curr. Biochem. 7 (1): 1-9  
1 
 
Curr. Biochem. 7(1): 1-9 
 
 
 
CURRENT BIOCHEMISTRY 
   ISSN: 2355-7877 
e-ISSN: 2355-7931 
Journal homepage: http://journal.ipb.ac.id/index.php/cbj 
Journal E-mail: current.biochemistry@gmail.com 
 
 
Antibacterial Activity of Leaf Extracts of Anredera cordifolia (Ten.) 
Steenis and Muntingia calabura L. Against Streptococcus pneumoniae 
 
Nuke Annisa Nasution1, I Made Artika1*, Dodi Safari2 
 
1Department of Biochemistry, IPB University, Bogor, 16680, Indonesia 
2Eijkman Institute for Molecular Biology, Jalan Diponegoro 69, Jakarta, 10430 
 
 
Received: 26 December 2019 ; Accepted: 20 January 2020 
 
Corresponding author : I Made Artika, Department of Biochemistry, IPB University  
e-mail: imart@ipb.ac.id 
ABSTRACT 
Antibacterial resistance in Streptococcus pneumoniae has been increasing and is one of 
ongoing global concern.  The need to find new antibacterial agents against Streptococcus 
pneumoniae is of paramount importance. Medicinal plants are prospective sources of antibacterial 
agents. The aims of the present study were to determine the activity of leaf extraxt of Anredera 
cordifolia (Ten.) Steenis and Muntingia calabura L. against Streptococcus pneumoniae.  Leaves of 
Anredera cordifolia (Ten.) Steenis were extracted using 96% ethanol, while the leaves of Muntingia 
calabura L were extracted using 100% methanol.  The leaf extracts of the two plants obtained were 
bioassayed for antibacterial activity against Streptococcus pneumoniae ATCC 49619 and a clinical 
isolate Streptococcus pneumoniae PU 067.  Results showed that leaf extracts of both Anredera 
cordifolia (Ten.) Steenis and Muntingia calabura L. have antibacterial activity in vitro against 
Streptococcus pneumoniae ATCC 49619 at crude extract concentrations of 25%, 50%, 75% and 
100% (w/v). Both plants extracts showed strongest activity against S. pneumoniae ATCC 49619 at 
extract concentration of 75%.   In addition, the extracts of both plants have inhibitory activity 
against growth of the clinical isolate Streptococcus pneumoniae PU 067. Both plant extracts 
showed strongest activity against S. pneumoniae PU 067 at extract concentration of 100%.  
Therefore, leaf extracts of Anredera cordifolia (Ten.) Steenis and Muntingia calabura L. can 
potentially be used as a source of antibacterial agent for Streptococcus pneumoniae.  
. 
Keywords: Antibacterial agent, Anredera cordifolia (Ten.) Steenis, Muntingia calabura L., 
Streptococcus pneumoniae. 
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1. INTRODUCTION 
Streptococcus pneumoniae was 
discovered in 1881, by two microbiologists 
independently, George M. Sternberg in the 
United States and Louis Pasteur in France.  
The bacterium was described as roughly 
lancet-shaped pairs of coccoid bacteria 
(Watson et al. 1993).  S. pneumoniae is a 
Gram positive bacterium, the most 
common cause of pneumonia in the elderly.  
The bacterium also causes of middle ear 
infections and meningitis in children.  
Currently, vaccine for the pneumococcus is 
available consisting of a mixture of 23 
different capsular polysaccharides. It is 
very effective in young adults, but only 
about 60% effective in the elderly and 
infected children under 2 years old. This is 
because children at this age group are 
unable to mount an antibody response to 
the pneumococcal polysaccharides.  
Antibiotics such as penicillin have played 
important roles in diminishing the risk 
from pneumococcal disease. Several 
pneumococcal proteins including 
pneumococcal surface proteins A and C, 
hyaluronate lyase, pneumolysin, autolysin, 
pneumococcal surface antigen A, choline 
binding protein A, and two neuraminidase 
enzymes are being investigated as potential 
vaccine or drug targets (Jedrzejas 2001).  
However, the emergence of drug-resistant 
S. pneumoniae, especially multidrug-
resistant (MDR) strains, decreases the 
effectiveness of antibiotics. 
Multidrug-resistant S. pneumoniae 
has spread worldwide. In addition, the 
spread of extensively drug-resistant (XDR) 
S. pneumoniae has also been reported (Cho 
et al. 2014).   Increased antimicrobial 
resistance in S. pneumoniae has been a 
worldwide concern mainly due to increase 
used of antibacterial agents (Golden et al. 
2015). The excessive use of antibacterial 
agents causes selective pressure that 
maintains strains harboring resistance 
genes once introduced into communities.  
It is well known that pneumococci have the 
ability to acquire resistance genes through 
natural transformation, even from other 
bacterial species (Vilhelmsson et al. 2000).  
Globally, S. pneumoniae causes ~582000 
to 926000 deaths annually and antibacterial 
agents have been the first option for 
treating these infections. Therefore, it is 
critical to search for new effective 
antibacterial agents against S. penumoniae. 
Plant extracts have been 
investigated for use as a source of novel 
antibacterial agents (Iauk et al., 2003; 
Njimoh et al., 2015; Rahmawati et al., 
2017). A. cordifolia (Ten.) Steenis, 
commonly known as “binahong” in 
Indonesia, is one of the medicinal plants 
that has been shown to have 
pharmacological activities.  In addition to 
its antibacterial activities, binahong has 
been reported to have antidiabetic, 
antiobesity,antihyperlipidemic,vasodilator
and wound healing activities (Leliqia et al. 
2017).  Previous studies have shown that 
ethanolic extract of A. cordifolia leaves 
showed antibacterial activities against 
Bacillus subtilis, Escherichia coli, 
methicillin-resistant coagulase-negative 
staphylococci (MRCNS), and 
Pseudomonas aeruginosa (Garmana et al. 
2014).  Other studies have also shown that 
an ethanolic extract, n-hexane and ethyl 
acetate fractions of A. cordifolia leaves 
have antibacterial activities against S. 
aureus, methicillin-resistant S. aureus 
(MRSA), Bacillus subtilis and Bacillus 
cereus (Leliqia et al. 2017).  Similarly, 
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Muntingia calabura L., commonly known 
as “kersen” in Indonesia, has been shown 
to have antibacterial acitivities and other 
pharmacological potential such as 
cytotoxic, antiproliferative, insecticidal, 
antioxidant, anti-inflammatory, 
hepatoprotective, hypotensive, 
antinociceptive, cardioprotective, 
antipyretic, antiplatelet aggregation, 
antiulcer and antidiabetic potential 
(Mahmood et al. 2014; Zakaria et al. 
2019). The ethyl acetate partition of 
Muntingia calabura L. leaves methanol 
extracts were found to effectively inhibit 
growth of Staphylococcus aureus 25923 
and S. aureus 33591 (a multi-drug resistant 
S. aureus, MRSA) (Zakaria et al. 2010).  
The methanol extracts of Muntingia 
calabura L. leaves and of Muntingia 
calabura L. fruits were also found to 
inhibit growth of Escherichia coli (C600) 
and S. aureus (209 P) (Mahmood et al. 
2014).  The present study was aimed to test 
the actibacterial activities of leaf extracts of  
A. cordifolia (Ten.) Steenis and Muntingia 
calabura L. against S. pneumoniae.  To the 
best of our knowledge, this is the first study 
exploring the antibacterial activity of A. 
cordifolia (Ten.) Steenis and Muntingia 
calabura L. leaf extracts against S. 
pneumonia. 
 
2. METHODOLOGY 
Preparation of Samples (Rahmi et al. 
2014) 
Samples in the form of A. cordifolia 
(Ten.) Steenis leaves were collected from 
Bogor, West Java, Indonesia.  Leaves were 
cleaned and washed under running water 
and then air-dried at room temperature 
protected from the sun.  The samples were 
then dried in the oven at 500C.  The dried 
samples were then ground and extracted. 
  
Extraction of samples (Rahmi et al. 
2014; Zakaria et al. 2019) 
Samples were extracted using a 
maceration technique.  A. cordifolia (Ten.) 
Steenis leaf samples were extracted using 
96 percent ethanol.  The sample 
preparation powder was soaked in the 
extracting solvent with sample:solvent 
ratio of 1:10 (w/v) for 24 h.  The sample 
preparation powder of Muntingia calabura 
L. leaf was extracted using 100% methanol 
with sample:solvent ratio of 1:4 (w/v) for 
24 h.  Both extracts were then concentrated 
using rotary vacuum evaporator.  Solvent 
free-extracts of A. cordifolia (Ten.) Steenis 
and Muntingia calabura L. were obtained, 
and then dissolved in ddH20.  Extract with 
concentration of 25%, 50%, 75%, and 
100% (w/v) was obtained by dissolving 
0.025 g, 0.050 g, 0.075 g, and 0.100 g of 
each extract in 100 mL ddH2O, 
respectively. 
 
Preparation of bacterial cultures (Safari 
et al. 2014) 
Bacterial strains, S. pneumoniae 
ATCC 49619 and a clinical isolate of S. 
pneumoniae, PU 067, which were then 
used for the extract susceptibility test, were 
firstly activated by growing them in blood-
agar medium under anaerobic conditions at 
370C,  CO2 level less than 5%, for 24 h. The 
bacterial growth was then observed. 
  
Extract Susceptibility Testing  
Extract susceptibility test for the 
pneumococcus isolates was carried out 
using the disk diffusion method according 
to Bauer et al. (1966). Following 
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incubation for 24 h, the testing bacteria 
were inoculated into an Eppendorf tube 
containing 2 mL of NaCl.  The bacterial 
suspension was vortexed and its turbidity 
was then compared to the McFarland 0.5 
turbidity standard. Using sterile cotton 
buds, the bacterial suspension was 
inoculated onto a blood-agar plate.  An 
extract-containing 6 mm disk was then 
applied onto the bacterial culture and the 
plate was incubated at 37oC for 24 h under 
anaerobic conditions.  The antibacterial 
activity was assayed by measuring the 
inhibition zone around the disk. 
 
 
3. RESULT 
Antibacterial activity of extract of 
Anredera cordifolia (Ten.) Steenis 
Extract of A. cordifolia (Ten.) Steenis 
was obtained in the form of a paste.  The 
yield of the extract was 9.53%.  The extract 
was then dissolved in ddH2O and used for 
antibacterial activity test.  Results of 
antibacterial activity test of the extract of 
A. cordifolia (Ten.) Steenis at various 
concentrations are shown in Table 1.   
The leaf extracts of A. cordifolia (Ten.) 
Steenis inhibited the growth of S. 
pneumoniae ATCC 49619 at crude extract  
 
 
Table 1.   Antibacterial activity of leaf extract of Anredera cordifolia (Ten.) Steenis 
Anredera cordifolia  
leaf extract concentration 
(%) 
Diameter of inhibition zone (mm) 
S. pneumoniae 
ATCC 49619 
S. pneumoniae 
PU 067 
25 10.9 8.0 
50 11.4 9.6 
75 14.0 10.9 
100 10.2 14.0 
ddH2O (negative control) 6.0 6.0 
Chloramphenicol (30 μg) 29.7 29.4 
 
 
 
Table 2.   Antibacterial activity of leaf extract of of Muntingia calabura L. 
Anredera cordifolia  
leaf extract concentration 
(%) 
Diameter of inhibition zone (mm) 
S. pneumoniae 
ATCC 49619 
S. pneumoniae 
PU 067 
25 13.0 9.0 
50 13.0 13.0 
75 13.3 13.4 
100 10.8 16.3 
ddH2O (negative control) 6.0 6.0 
Chloramphenicol (30 μg) 29.7 29.4 
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concentrations of 25%, 50%, 75% and 
100% (w/v). Similarly, the extracts 
inhibited the growth of S. pneumonia PU 
067 at crude extract concentrations of 
25%, 50%, 75% and 100% (w/v).  The 
optimum extract concentration to inhibit 
S. pneumoniae ATCC 49619 and S. 
pneumonia PU 067 was 75% and 100%, 
respectively.  The inhibitory activity of 
the extract at all concentrations tested was 
lower than that of chloramphenicol (30 
μg) against the two strains. 
 
Antibacterial activity of leaf extract of 
Muntingia calabura L. 
 Extract of Muntingia calabura L. 
was also obtained in the form of a paste 
with a yield of 9.54%.  The extract was 
then dissolved in ddH2O and used for 
antibacterial activity test.  Results of 
antibacterial activity test at various 
extract concentrations are shown in Table 
2.  The leaf extracts of Muntingia 
calabura L inhibited the growth of 
Streptococcus pneumoniae ATCC 49619 
at crude extract concentrations of 25%, 
50%, 75% and 100% (w/v). Similarly, the 
extracts inhibited the growth of resistant 
Streptococcus pneumonia isolate at crude 
extract concentrations of 25%, 50%, 75% 
and 100% (w/v).  The optimum 
Muntingia calabura L extract 
concentration to inhibit S. pneumoniae 
ATCC 49619 and S. pneumonia PU 067 
was 75% and 100%, respectively.  The 
inhibitory activity of the Muntingia 
calabura L extract at all concentrations 
tested was also found to be lower than 
that of chloramphenicol (30 μg) against 
the two strains. 
 
 
4. DISCUSSION  
We report experimental data of 
antibacterial activity of leaf extracts of 
binahong (Anredera cordifolia (Ten.) 
Steenis) and kersen (Muntingia calabura 
L.) at various concentrations against S. 
pneumoniae in attempt to search for novel 
sources of antibacterial agents against S. 
penumoniae including the MDR and 
XDR strains.  This is important as 
resistant strains of S. pneumoniae have 
been reported to be present in Indonesia 
(Safari et al., 2014).  Two S. pneumoniae 
strains were used in this study, the S. 
pneumoniae ATCC 49619 and a 
multidrug resistant clinical isolate, S. 
pneumoniae PU 067.  The strain S. 
pneumoniae PU 067 is resistant towards 
penicillin group antibiotics, oxacillin, 
sulfamethoxazole/trimethoprim, and 
tetracycline (Saputro 2013).  In the 
present study, the extracting solvents 
used were ethanol 96% to produce leaf 
extract of Anredera cordifolia (Ten.) 
Steenis and methanol 100% to produce 
leaf extract of Muntingia calabura L.  For 
antibacterial assays, ddH2O was used as a 
negative control and chloramphenicol (30 
μg) was employed as a positive control.  
Our results showed that the leaf extracts 
of binahong and kersen have inhibitory 
activity against both S. pneumoniae 
ATCC 49619 and S. pneumoniae PU 067.  
The activity, however, is lower than the 
activity of the antibiotic 
chloramphenicol. The inhibitory activity 
against S. pneumonia PU 067 tended to 
increase with the increase concentration 
of both Anredera cordifolia (Ten.) 
Steenis and Muntingia calabura L 
extracts.   Compared to the Anredera 
cordifolia (Ten.) Steenis extract, the 
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Muntingia calabura L extract seemed to 
be slightly more potent in inhibiting the 
growth of the multidrug resistant S. 
pneumonia PU 067. Interestingly, both 
plants extracts showed a higher optimum 
concentration to inhibit the S. 
pneumoniae PU 067.  The reasons for this 
have yet to be elucidated but may be 
associated with the resistant 
characteristics of the S. pneumoniae PU 
067 strain.  Further studies, therefore, are 
required to elucidate the compounds 
responsible for the antibacterial activity 
and the molecular mechanism underlying 
the S. pneumoniae growth inhibitory 
activity. 
In Indonesia, the availability of 
data on the spread and disease level of S. 
pneumoniae are limited among the 
Indonesian population. It was reported 
that S. pneumoniae spread in Lombok 
Island in 2001 was 48% in healthy 
children.  Similarly, S. pneumoniae 
spread in Semarang in 2010 was reported 
to be 43% in children aged 6-60 months 
and and 11% in adults aged 45-75.  In 
HIV-infected group of children in Jakarta 
the S. pneumoniae it was 46%, and 3% in 
elderly age 60-80 years attending routine 
visits at the Geriatric Clinic, Dr Cipto 
Mangunkusumo Hospital, Jakarta (Safari 
et al. 2015). The serotypes of S. 
pneumoniae identified from the HIV 
infected children in Jakarta include 
serotype 19F, 19A, 6A/B and 23F. Most 
of the isolates were susceptible to 
chloramphenicol, clindamycin, and 
erythromycin, but resistant to penicillin 
(Safari et al. 2014).  Globally, there has 
been a dramatic increase in the incidence 
of penicillin-resistant and multiply-
antibiotic-resistant pneumococci 
worldwide since 1967 (Charpentier and 
Toumanen 2000).  The mechanism of 
penicillin resistance in S. pneumoniae has 
been suggested to involve the alteration 
of Penicillin-binding proteins (PBPs) 
which leads to reduced affinity of the 
PBPs to the antibiotic molecule. 
Mutations leading to penicillin resistance 
usually occur in the transpeptidase-
penicillin-binding domain. Multiple 
mutations are required for high-level 
resistance to occur. In pneumococcus, 
five PBPs of high molecular weight 
(PBPs 1a, 1b, 2x, 2a and 2b) and one PBP 
of low molecular weight have been 
reported. Mutations in PBP2x and PBP2b 
bring about low-level resistance and are 
the prerequisite for high-level resistance 
mediated by mutations in other PBPs, like 
PBP1a. In many pneumococcal clinical 
isolates resistance is caused by changes in 
these three PBPs only (Charpentier and 
Toumanen 2000).   
Binahong is a medicinal plant 
belonging to the family of Basellaceae, 
and is considered to have high potency for 
phytopharmaceutical sources.  Binahong 
has been reported to contain chemical 
constituents such as flavonoid, oleanolic 
acid, protein, saponins, steroids, 
terpenoids, phenols, polyphenols, 
alkaloids tannin, ascorbic acid, and mono 
polysaccharides including L-arabinose, 
D-galaktose, and L-rhamnose (Astuti 
2011; Wijayanti and Esti 2017; Yuniarti 
and Lukiswanto 2017).  The antibacterial 
activity of binahong leaf has been 
reported (Miladiyah and Prabowo 2012; 
Yuniarti and Lukiswanto 2017).  The 
bioactive compounds of binahong have 
been indicated to play roles in its 
antibacterial activities against both Gram- 
Curr. Biochem. 7 (1): 1-9  
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positive and Gram-negative bacteria 
including those causing sexuality 
transmitted diseases (Astuti 2011).   
Kersen is a plant introduced from 
Tropical America to Southeast Asia and 
has traditional medicinal usage in various 
modes of applications.  Kersen have been 
suggested to have anti-inflammatory, 
anti-nociceptive antioxidant and 
antimicrobial activites as well as 
cytotoxicity against leukemia cell lines.  
The ethanolic leaf extracts of M. calabura 
were reported to contain sterols, 
flavonoids, alkaloids, saponins, 
glycosides, and tannins.  Triterpenes were 
not detected in the leaf extracts but 
detected in the stem extracts of the plant.  
The M. calabura extracts were found to 
have antibacterial activity against 
Pseudomonas aeruginosa and 
Staphylococcus aureus.  The 
polyphenols, especially the flavonoids 
have been linked to the antibacterial 
activities (Buhian et al. 2016).   
Extraction is a critical step in the 
evaluation of antibacterial activity 
medicinal plants.  It is important to ensure 
that the chemical components having 
antibacterial activities are extracted from 
the plant materials.  The basic steps in 
preparing plant extract include pre-
washing, drying of plant materials or 
freeze drying, grinding to obtain a 
homogenous sample and often improving 
the kinetics of analytic extraction and also 
increasing the contact of sample surface 
with the solvent system. Care must be 
taken to prevent lost of potential active 
constituents. If the plants are selected on 
the basis of traditional uses it is necessary 
to prepare the extract as described by the 
traditional healer in order to mimic as 
closely as possible the traditional ‘herbal’ 
drug.  Extraction methods using polar 
solvents such as methanol, ethanol or 
ethyl-acetate are generally used to extract 
hydrophilic compounds. For extraction of 
more lipophilic compounds, 
dichloromethane or a mixture of 
dichloromethane/methanol can be used 
(Sasidharan et al. 2011). In the present 
study, binahong leaf was extracted by 
maceration using 96% ethanol and the 
kersen leaf was extracted by the same 
technique using methanol 100%.  The 
extracts showed antibacterial activity 
against S. pneumoniae ATCC 49619 and 
a clinical isolate of MDR S. pneumoniae.  
Future studies employing a more 
systematic and comprehensive approach 
is required to confirm the potency of A. 
cordifolia (Ten.) Steenis) and M. 
calabura L. leaves as a source of novel 
antipneumococcal agents.  Modern 
extraction techniques such as solid-phase 
micro-extraction, supercritical-fluid 
extraction, pressurized-liquid extraction, 
microwave-assisted extraction, solid-
phase extraction, and surfactant-mediated 
techniques, possess certain advantages 
(Sasidharan et al. 2011) and may be 
applicable for extracting compounds with 
antibacterial activities from A. cordifolia 
(Ten.) Steenis and M. calabura L. 
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